A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program

Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme

(2010) John Lasala et al.   EuroIntervention

Incomplete Revascularization in the Era of Drug-Eluting Stents

(2009) Edward L. Hannan et al.   JACC-Cardiovascular Interventions

Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform

(2008) Craig A. Thompson et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

A review of current devices and a look at new technology: drug-eluting stents

(2008) Gaku Nakazawa et al.   Expert Review of Medical Devices

Direct Stenting With the TAXUS Liberté Drug-Eluting Stent

(2008) John A. Ormiston et al.   JACC-Cardiovascular Interventions

Reduced Risk of Restenosis in Small Vessels and Reduced Risk of Myocardial Infarction in Long Lesions With the New Thin-Strut TAXUS Liberté Stent

(2008) Mark A. Turco et al.   JACC-Cardiovascular Interventions

Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease

(2008) Gregg W. Stone   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

One-Year Outcomes with the TAXUS Liberté Stent in the Real World: The TAXUS OLYMPIA Registry (Phase I)

(2008) WAQAR HABIB AHMED et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

(2008) Stephan Windecker et al.   LANCET

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

(2007) Spencer B. King et al.   CIRCULATION